Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana S Cruz

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 16, 2017
Melding a High-Risk Patient for Continuous Flow Left Ventricular Assist Device into a Low-Risk PatientJavier Amione-Guerra, Ana S Cruz-Solbes, Hilda Gonzalez Bonilla, et al.
Plos One|October 20, 2022
Readmission rates and risk factors for readmission after transcatheter aortic valve replacement in patients with end-stage renal diseaseDae Yong Park, Seokyung An, Jonathan M Hanna, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|October 19, 2020
Endothelial Dysfunction-related Neurological Bleeds with Continuous Flow-Left Ventricular Assist Devices Measured by Digital Thermal MonitorAreeba Ali, Cesar Uribe, Raquel Araujo-Gutierrez, et al.
Journal of Clinical Medicine|May 1, 2019
Implication of Ventricular Assist Devices in Extracorporeal Membranous Oxygenation Patients Listed for Heart TransplantationAshrith Guha, Bashar Hannawi, Ana S Cruz-Solbes, et al.
International Journal of Pharmaceutics|April 1, 2017
Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertensionVictor Segura-Ibarra, Javier Amione-Guerra, Ana S Cruz-Solbes, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|September 9, 2017
Risk Stratification of Patients With Current Generation Continuous-Flow Left Ventricular Assist Devices Being Bridged to Heart TransplantationAshrith Guha, Duc Nguyen, Ana S Cruz-Solbes, et al.
The International Journal of Artificial Organs|August 9, 2022
Tissue plasminogen activator in left ventricular assist device-related intravascular hemolysis after failed augmented anticoagulationRobert Kenneth Sims, Nina Srour, Lamees I El Nihum, et al.
Cardiovascular Research|July 26, 2024
Inhibition of endothelial-to-mesenchymal transition in a large animal preclinical arteriovenous fistula model leads to improved remodelling and reduced stenosisYang Xu, Adam Korayem, Ana S Cruz-Solbes, et al.
European Journal of Heart Failure|January 11, 2016
A specifically designed nanoconstruct associates, internalizes, traffics in cardiovascular cells, and accumulates in failing myocardium: a new strategy for heart failure diagnostics and therapeuticsGuillermo U Ruiz-Esparza, Victor Segura-Ibarra, Andrea M Cordero-Reyes, et al.
Mbio|May 17, 2018
Inducible Lung Epithelial Resistance Requires Multisource Reactive Oxygen Species Generation To Protect against Viral InfectionsCarson T Kirkpatrick, Yongxing Wang, Miguel M Leiva Juarez, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 16, 2017
Melding a High-Risk Patient for Continuous Flow Left Ventricular Assist Device into a Low-Risk PatientJavier Amione-Guerra, Ana S Cruz-Solbes, Hilda Gonzalez Bonilla, et al.
Plos One|October 20, 2022
Readmission rates and risk factors for readmission after transcatheter aortic valve replacement in patients with end-stage renal diseaseDae Yong Park, Seokyung An, Jonathan M Hanna, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|October 19, 2020
Endothelial Dysfunction-related Neurological Bleeds with Continuous Flow-Left Ventricular Assist Devices Measured by Digital Thermal MonitorAreeba Ali, Cesar Uribe, Raquel Araujo-Gutierrez, et al.
Journal of Clinical Medicine|May 1, 2019
Implication of Ventricular Assist Devices in Extracorporeal Membranous Oxygenation Patients Listed for Heart TransplantationAshrith Guha, Bashar Hannawi, Ana S Cruz-Solbes, et al.
International Journal of Pharmaceutics|April 1, 2017
Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertensionVictor Segura-Ibarra, Javier Amione-Guerra, Ana S Cruz-Solbes, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|September 9, 2017
Risk Stratification of Patients With Current Generation Continuous-Flow Left Ventricular Assist Devices Being Bridged to Heart TransplantationAshrith Guha, Duc Nguyen, Ana S Cruz-Solbes, et al.
The International Journal of Artificial Organs|August 9, 2022
Tissue plasminogen activator in left ventricular assist device-related intravascular hemolysis after failed augmented anticoagulationRobert Kenneth Sims, Nina Srour, Lamees I El Nihum, et al.
Cardiovascular Research|July 26, 2024
Inhibition of endothelial-to-mesenchymal transition in a large animal preclinical arteriovenous fistula model leads to improved remodelling and reduced stenosisYang Xu, Adam Korayem, Ana S Cruz-Solbes, et al.
European Journal of Heart Failure|January 11, 2016
A specifically designed nanoconstruct associates, internalizes, traffics in cardiovascular cells, and accumulates in failing myocardium: a new strategy for heart failure diagnostics and therapeuticsGuillermo U Ruiz-Esparza, Victor Segura-Ibarra, Andrea M Cordero-Reyes, et al.
Mbio|May 17, 2018
Inducible Lung Epithelial Resistance Requires Multisource Reactive Oxygen Species Generation To Protect against Viral InfectionsCarson T Kirkpatrick, Yongxing Wang, Miguel M Leiva Juarez, et al.
Pageof 2